nsclc
-
&gt
&gt &# n cardiovascular
&lt
a cause
a decrease of g
a diuretic
a low value
abdomen
acetazolamide
acute
addition of heparin
additionally
age
aicd discharge
alcohol
all
all adverse experiences a fumarate
all benzodiazepines
all body systems
alone n
also
also seen
also seen at &gt
although
among racial groups
analgesics
anaphylactic
and
anf
ankle
anogenital regions
anticholinergic
antiemetics
antihistamines
antimitochondrial antibodies
antipyretics
anxiolytic
any dose n
any side effect
appearance
appendages
applesauce
appropriate countermeasures
appropriate therapy instituted immediately
approximately to
as follows
at doses of
atenolol
atropine
attempt
atypical antipsychotic
available
axis deviation
b
back
beta-blocking
between elderly
black
blacks and non-blacks
blood
blood chemistry
blood chemistry analyses
body
body as a whole
body as a whole -
body system adverse experience
bone
both
but
but not limited to
butnot limited to
by checklist
can result in complications
carbamazepine
cardiac rhythm
cardiovascular
cardiovascular events
carvedilol
central
central &amp
central &amp peripheral
characterized by rhythmical
che
chest
children
chlordiazepoxide
chlorpromazine
clcr
clcr in ml
clinical adverse experiences probably
clinical comparing timolol maleate
clinical laboratory findings
clinical pharmacology
clinically significant events
clonazepam
clozapine
cns
cns reactions neuromuscular
colon may be affected
colon problem
comparison of gender
complaints
confirmed by rechallenge
controlled
conventional therapy plus
conventional therapy plus n
corpus luteum
cross
cross-sensitivity with desipramine
cutaneous
daily dose
day
day for up to
day of alprazolam
day of alprazolam tablets
days
decreased
decreased performance
definitely related
delayed onset of hit
dental
dermatological
desaturation
diazepam
digestive
digestive system
discoloration
discontinuation hydrochloride tablets n
discontinuation weeks
discontinue the drug
discontinuing therapy
discussed above
disorder
disturbances
diuretics
dosage and administration
dose
dose dependent
dose related
dose-related
doses of
double-blind
dreaming
duration
duration of therapy
duration of treatment
during clinicals
during premarketing s
e g
each
ear
effect
effects
either reversible or irreversible
elderly and non-elderly
elevation
elevations
elicited
elicited foreign us studies
emotional
epigastric
especially in the elderly
especially narcotics
estazolam
etc
etiology
even years
event
events that
every h mild
every h moderate
every h severe
example
extracardiac
extremities
eye
eyes
face
fatalities
female
females
fetal
first
follows
for example
for immediate formulations
for immediate-release formulations
for the most part
foreign studies
four weeks
fourth weeks of treatment
frequency
frequent
from all
furthermore
gastrointestinal
gastrointestinal system
gastrointestinal system disorder
gastrointestinal sytem disorder
general
generally
genitourinary disorder
glottis
greater
greater than
greater than one year
greater than year
group receiving lamotrigine tablets
groups
groups by body system
gum
gums
have also been reported
have been reported
hcl n
head
heart rate rhythm
heat
hematologic
hematologic lymphatic systems
hematological disorder
hematopoietic
hemic
hemic lymphatic
hepatobiliary tract
high dose n
high hematology
higher
hodgkin
hour
however
hydrochlorothiazide
hypo-
i e
identified
idiosyncratic
iii
iii effects
immune system
immunologic in rare cases
incapacitating
incidence discontinuation
incidence of or greater
included
increased
increases
indications
individuals
induced pseudo
infrequent 
intensification
intrafat
isis-
isoniazid
it was mild
ities abnormal
iv phenytoin adverseevent
jaw
joint
juices
keep patient lying down
kg dose group
kidneys
l in one
l in the other
l to iu
l to lu
laboratory deviations
laboratory tests
lamotrigine
larynx occurs
lens
less
less commonly reported
less than
less than bpm
light
like other beta blockers
like other beta-blockers
lip
lips
lisinopril
listed by body system
listed by system
liver
long periods of therapy
long-term use
lorazepam
low
lungs
ly
lymphatic
lymphatic systems
male
males
management
marketed levetiracetam
marketing experience
maximum daily dose all
may be dose-related
may occur
mcg
measles-like
mechanism of occurrence
mental
metabolic
metabolic nutritional
metabolism
metoprolol
metoprolol n body as a whole
mild
min
min needed
min rate
minor
miscellaneous complaints
ml min
months with carvedilol
more
more frequently with lisinopril
more severe reactions
mortality
mortality -
mouth or jaw
muscle
musculoskeletal
musculoskeletal connective tissue
musculoskeletal system
myocardium
n =
n a
n by body system
n cardiovascular
n for male for female
n for male for female female
n incidence
n n
n no gastrointestinal
neuroleptic drugs
neurologic
neurological
neuromuscular
neuropsychometrics
nlein purpura
non-blacks
non-elderly
none reported
nonetheless
nonspecific
normochromic
nose
not necessarily concurrently
not otherwise specified
number
observe for at least
occasionally
occurred in about to
of one
of these
oid reactions
one
one-year
onset
or of face
oral
oral hypoglycemic agents
organophosphorus insecticides
organs
orthostatic
others
ovarian
over
over to minutes
overall
pancreas
partial
participated in controlled clinicals
patient
patient-episodes
pediatric use
percent
perl
personality
phenobarbital
phenytoin
place
platelet
practolol
precautions
premorbid state abnormal
presumably a metabolite
primidone
progestin
prolonged
propranolol
propranolol n
protracted
pseudo
psychiatric
psychiatric disorder
quinidine-like effect
quinidinelike effect
race
randomized
rare
rarely
rarer
rate in a randomized
rate related
rbc
rbc hpf
reactions
reassurance
reassured
received oral sotalol
received since marketing
recovery
reduction
reflexes
reinfraction
related reactions
relatively short duration
renal
repiratory diseases
reported
reported in
reported infrequently
reports
reproduction disorder
reproductive
reproductive disorder &# female
required
respectively
respiration
respiratory
respiratory system
reversible
rhythm
rifampin
s disease
scalp
second
secretion
secretion syndrome
sedative
see
seen at the
seen once are listed
sensitization
sensory
serious
serous membranes
severe
sex
short
short-term
should these occur
shown to be effective
significantly greater than
signs
signs increased
signs or symptoms
single instances of first-degree
skin
skin appendages
skin appendages disorder
soda or soda-like beverages
some are dose-related
some severe
sometimes fatal
special populations
special senses
special senses other
spo of
sporanox
standard meddra terminology
start antibiotic
start appropriate therapy
stop treatment
subcutaneous
sudden
sugar
suitable therapy
symptoms
system
system disorder
system neuromuscular
table
table enumerates the incidence
tablets n
tabulations that follow
terbinafine hydrochloride tablets
the abuse
the cardiovascular system
the dosage of intravenous
the following
the most common
the most common events
the most commonly observed
the most frequent reasons
the overall safety
the piperazine group
the safety
the signs
the skin
the thiazides
therapy should be discontinued
therefore
these sensations
these signs
they may be persistent
thioridazine
third
third trimester fetal
thirty
thoracic
throat
thus
tissues
to date
to mg n
to months
to years of age
tongue
total
total &# volunteered elicited foreign us studies
total - volunteered volunteered us studies
transient
transient in nature
treatment
trunk
tumor
two years duration
u s studies
units per infusion
unspecified
untoward event
untoward events enumerated above
up to
urinary
urinary system
urogenital
us studies
usp
usp in a double-blind
usually between the second
usually mild
usually mild to moderate
usually reversible
usually reversible q
usually self-limited
usually transient
valproate
valproic acid
vascular
versus
very
very important
vision
vol
vol percent
volunteered u s studies
volunteered us studies
warnings
week
when
when adverse reactions occur
when first observed
which
which are usually transient
while often mild
while the severity
who received
with all benzodiazepines
with discontinuation
with long-term use
within two weeks
women
years of age
